Physicochemical Properties
| Molecular Formula | C7H14N4 |
| Molecular Weight | 154.21300 |
| Exact Mass | 154.122 |
| CAS # | 1113-10-6 |
| PubChem CID | 14211 |
| Appearance | White to off-white solid powder |
| Density | 1.02g/cm3 |
| Boiling Point | 239.3ºC at 760 mmHg |
| Flash Point | 98.5ºC |
| Vapour Pressure | 0.0404mmHg at 25°C |
| Index of Refraction | 1.504 |
| LogP | 1.651 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 3 |
| Heavy Atom Count | 11 |
| Complexity | 196 |
| Defined Atom Stereocenter Count | 0 |
| InChi Key | VZVGEDRCVUKSEL-UHFFFAOYSA-N |
| InChi Code | InChI=1S/C7H14N4/c1-4-7(2,3)11-6(9)10-5-8/h4H2,1-3H3,(H3,9,10,11) |
| Chemical Name | 1-cyano-2-(2-methylbutan-2-yl)guanidine |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| References |
[1]. Guancydine: a new antihypertensive agent. Use with quinethazone and guanethidine or propranolol. Ann Intern Med. 1972 Apr;76(4):579-85. |
| Additional Infomation | Guancidine is a member of guanidines. |
Solubility Data
| Solubility (In Vitro) | DMSO : ≥ 125 mg/mL (~810.58 mM) |
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.08 mg/mL (13.49 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 2.08 mg/mL (13.49 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. Solubility in Formulation 3: ≥ 2.08 mg/mL (13.49 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 6.4847 mL | 32.4233 mL | 64.8466 mL | |
| 5 mM | 1.2969 mL | 6.4847 mL | 12.9693 mL | |
| 10 mM | 0.6485 mL | 3.2423 mL | 6.4847 mL |